These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28957603)

  • 1. THE CARDIOVASCULAR SYSTEM IN TYPE 2 DIABETES MELLITUS AND THYROID DISORDERS IN THE ABSENCE OF THYROID GLAND DYSFUNCTION.
    Ballyizek MF; Ignat'eva Pa
    Klin Med (Mosk); 2016; 94(4):260-264. PubMed ID: 28957603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Age characteristics of the cardiovascular system, depending on the thyroid function in type 2 diabetes mellitus].
    Ignateva PA; Ballyuzek MF; Shpakov AO
    Adv Gerontol; 2015; 28(4):755-761. PubMed ID: 28509467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid gland diseases in adult patients with diabetes mellitus.
    Vondra K; Vrbikova J; Dvorakova K
    Minerva Endocrinol; 2005 Dec; 30(4):217-36. PubMed ID: 16319810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative analysis of the changing pattern of thyroid disease in patients with type 2 diabetes mellitus in the Perm region after 10 years].
    Tereshchenko IB; Suslina AA
    Ter Arkh; 2014; 86(10):15-9. PubMed ID: 25509886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid ultrasound in diabetic patients without overt thyroid disease.
    Junik R; Kozinski M; Debska-Kozinska K
    Acta Radiol; 2006 Sep; 47(7):687-91. PubMed ID: 16950706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease.
    Pearce EN; Bogazzi F; Martino E; Brogioni S; Pardini E; Pellegrini G; Parkes AB; Lazarus JH; Pinchera A; Braverman LE
    Thyroid; 2003 Jul; 13(7):643-8. PubMed ID: 12964969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Affection of cardiovascular system in diabetic patients with thyroid dysfunctions].
    Schroner Z; Lazúrová I
    Vnitr Lek; 2006 Nov; 52(11):1069-76. PubMed ID: 17165527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthostatic hypotension in diabetic patients-10-year follow-up study.
    Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
    J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
    Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
    J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The changes in hormonal status of the cardiovascular and the thyroid systems in rats with 18-month type 2 diabetes mellitus].
    Derkach KV; Ignatieva PA; Bogush IV; Balluzek MF; Shpakov AO
    Adv Gerontol; 2016; 29(2):262-268. PubMed ID: 28514543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid dysfunction in patients with type 2 diabetes mellitus].
    Tereshchenko IV; Suslina AA
    Ter Arkh; 2014; 86(8):119-23. PubMed ID: 25306758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
    Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study.
    Henry RM; Paulus WJ; Kamp O; Kostense PJ; Spijkerman AM; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD
    Neth J Med; 2008 Mar; 66(3):110-7. PubMed ID: 18349466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic function is not associated with the incidence of type 2 diabetes in a high-risk population: the Hoorn study.
    Hillebrand S; de Mutsert R; den Heijer M; le Cessie S; Stehouwer CD; Nijpels G; Dekker JM
    Diabetes Metab; 2014 Apr; 40(2):128-36. PubMed ID: 24308949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies.
    Kadiyala R; Peter R; Okosieme OE
    Int J Clin Pract; 2010 Jul; 64(8):1130-9. PubMed ID: 20642711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Mendivil CO; Kattah W; Orduz A; Tique C; Cárdenas JL; Patiño JE
    J Diabetes Complications; 2016; 30(1):93-8. PubMed ID: 26525688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
    Zosin I; Balaş M
    Endokrynol Pol; 2012; 63(1):2-9. PubMed ID: 22378090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
    Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes.
    Severinski S; Banac S; Severinski NS; Ahel V; Cvijović K
    Coll Antropol; 2009 Mar; 33(1):273-9. PubMed ID: 19408637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid disease and the cardiovascular system.
    Danzi S; Klein I
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):517-28. PubMed ID: 24891175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.